Therapeutic strategies to target microbial protein–glycosaminoglycan interactions

2018 
Glycans are involved in a plethora of human pathologies including infectious diseases. Especially, glycosaminoglycans (GAGs), like heparan sulfate and chondroitin sulfate, have been found to be involved in different crucial stages of microbial invasion. Here, we review various therapeutic approaches, which target the interface of host GAGs and microbial proteins and discuss their limitations and challenges for drug development.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    95
    References
    3
    Citations
    NaN
    KQI
    []